MAPT and Alzheimer disease: In particular, mTOR was reported to be up-regulated in selected neurons of AD brains that are predicted to develop tau pathology, suggesting that chronic high levels of mTOR signaling may exert detrimental effects in AD brains [41,65,66,67,68].